CUAMC
ACHL

China Universal Asset Management Company’s Achilles Therapeutics ACHL Stock Holding History

China Universal Asset Management Company’s Portfolio ACHL Stock Details ACHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-366
Closed -$1K – 479
2022
Q3 		$1K Buy
+366
New +$1.04K ﹤0.01% 423

Other funds holding ACHL

SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

China Universal Asset Management Company's ACHL Position: Q4 2022 in Review

China Universal Asset Management Company sold out of Achilles Therapeutics (ACHL) in Q4 2022, closing a stake of 366 shares — an estimated $1K sold.

China Universal Asset Management Company first reported a position in ACHL in Q3 2022 and held it in 1 quarter. The position peaked at $1K in Q3 2022. 23 funds tracked by Wall St. Rank hold ACHL as of Q4 2022.

  • China Universal Asset Management Company reported no remaining Achilles Therapeutics position as of Q4 2022 after selling out during the quarter.
  • China Universal Asset Management Company sold 366 Achilles Therapeutics shares in Q4 2022, an estimated $1K.
  • China Universal Asset Management Company first reported a position in Achilles Therapeutics in Q3 2022 and held it in 1 quarter.
  • China Universal Asset Management Company's Achilles Therapeutics position peaked at $1K in Q3 2022.
  • 23 funds tracked by Wall St. Rank held Achilles Therapeutics as of Q4 2022.

Based on China Universal Asset Management Company's 13F filing for Q4 2022, filed 31 Jan 2023.